Dr. Sahin released statements to the MUSC press about our work. Here is the press release:
PhD candidate Kubra was awarded the Hollings Fellowship for her research titled “Targeting Triple-Negative Breast Cancer with High Chromosomal Instability.”
“Hollings team marks milestone in progress toward investigational new drug for triple-negative breast cancer” https://hollingscancercenter.musc.edu/news/archive/2024/07/22/lox-inhibitor-for-triple-negative-breast-cancer
A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancer https://www.sciencedirect.com/science/article/pii/S2451945624002733?via%3Dihub
0 Comments